Enalapril

CD59 molecule (CD59 blood group) ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 9036753 Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease. 1997 Feb 1 1
2 8678058 Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial. 1996 Apr 1
3 8739285 Enalapril attenuates the renal hemodynamic effect of acetazolamide in patients with diabetes mellitus: possible implications for tubuloglomerular feedback. 1996 1
4 7742150 Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects. 1995 Feb 2
5 7830033 Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy. 1995 Jan 2
6 8158883 Long-term enalapril treatment in diabetic nephropathy. 1994 Feb 2
7 8346593 [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial]. 1993 Aug 2 2
8 1752291 The effect of angiotensin-I converting enzyme inhibition on insulin action in healthy volunteers. 1991 Oct 2
9 2544817 Enalapril attenuates glomerular hyperfiltration following a meat meal. 1989 1
10 2832173 The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure. 1988 Feb 2
11 3004546 Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. 1986 Jan 1